sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Co-suspect products included COVID-19 vaccine for prophylaxis. On an unknown date, the patient received Arexvy and COVID-19 vaccine. On an unknown date, an unknown time after receiving Arexvy, the patient experienced pain in arm (Verbatim: sore arm). The outcome of the pain in arm was not resolved. The reporter considered the pain in arm to be related to Arexvy. The company considered the pain in arm to be related to Arexvy. Additional Information: GSK receipt date: 02-DEC-2024 This case was reported by a patient via interactive digital media. Reporter reported that, she went right away and received her RSV and new Covid vaccine on same day. The RSV packed quite a punch with a sore arm but she was good as new and protected. The reporter considered the pain in arm to be related to COVID-19 vaccine. The follow-up could not be possible as no contact details were available.